| Ai-Media Technologies Limited (AIM) ORDINARY FULLY PAID |
Industrials |
$48 |
AGM Date and Closing Date for Director Nominations
|
17 Jul 2025 9:58AM |
$0.560 |
$0.230 |
fallen by
58.93%
|
|
| Horizon Gold Limited (HRN) ORDINARY FULLY PAID |
Materials |
$201 |
Trading Halt
|
17 Jul 2025 9:58AM |
$0.520 |
$1.030 |
risen by
98.08%
|
|
HRN - Price-sensitive ASX Announcement
Full Release
Key Points
- Horizon Gold Limited (ASX: HRN) requested a trading halt on 20 June 2023
- The trading halt is pending an announcement on a capital raising
- The halt will remain until either the capital raising announcement or market open on 22 June 2023
- Purpose is to ensure an orderly market while the announcement is prepared
- Request was lodged by the Company Secretary with the ASX
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Horizon Gold Limited (HRN) ORDINARY FULLY PAID |
Materials |
$201 |
Pause in Trading
|
17 Jul 2025 9:56AM |
$0.520 |
$1.030 |
risen by
98.08%
|
|
HRN - Price-sensitive ASX Announcement
Full Release
Key Points
- Horizon Gold Limited (ASX: HRN) requested a trading halt on 11 May 2023.
- The trading halt was pending the release of a material announcement.
- The halt was requested to ensure fair and orderly trading.
- Trading was to resume on the earlier of 15 May 2023 or upon announcement.
- The company emphasized its commitment to timely disclosure to the market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Beacon Minerals Limited (BCN) ORDINARY FULLY PAID |
Materials |
$369 |
Change of Director's Interest Notice x3
|
17 Jul 2025 9:56AM |
$1.150 |
$3.210 |
risen by
179.13%
|
|
| Immuron Limited (IMC) ORDINARY FULLY PAID |
Health Care |
$13 |
Notice under section 708A
|
17 Jul 2025 9:56AM |
$0.065 |
$0.039 |
fallen by
40%
|
|
| Elementos Limited (ELT) ORDINARY FULLY PAID |
Materials |
$162 |
Application for quotation of securities - ELT
|
17 Jul 2025 9:55AM |
$0.120 |
$0.370 |
risen by
208.33%
|
|
| Metallium Limited (MTM) ORDINARY FULLY PAID |
Materials |
$295 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
17 Jul 2025 9:53AM |
$0.870 |
$0.400 |
fallen by
54.02%
|
|
MTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Positive exploration results from the Pomme Rare Earths-Niobium Project in Quebec, Canada.
- Completion of a diamond drilling program with promising assays for rare earth elements and niobium.
- Fieldwork commenced at Western Australian lithium and rare earths projects.
- Exploration partnerships and grant applications to support project development.
- Acquisition of new tenements to expand the critical metals project portfolio.
- Cash balance at quarter end was $2.68 million.
- Expenditure mainly directed toward exploration and evaluation activities.
- No production or development activities during the quarter.
- Corporate update included grant of performance rights and new board appointments.
- No payments to related parties were made outside of standard remuneration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Charter Hall Social Infrastructure REIT (CQE) ORDINARY UNITS FULLY PAID |
Real Estate |
$965 |
CQE AMIT Notice 30 June 2025 Distribution
|
17 Jul 2025 9:49AM |
$2.900 |
$2.600 |
fallen by
10.34%
|
|
| Australian Rare Earths Limited (AR3) ORDINARY FULLY PAID |
Materials |
$27 |
Response to ASX Price Query
|
17 Jul 2025 9:48AM |
$0.088 |
$0.105 |
risen by
19.32%
|
|
AR3 - Price-sensitive ASX Announcement
Full Release
Key Points
- The ASX queried Australian Rare Earths Limited (AR3) about recent significant movements in the company's share price and trading volume.
- AR3 responded that it was not aware of any information concerning the company that had not been announced to the market and which, if known, could explain the recent trading activity.
- The company confirmed its compliance with the continuous disclosure obligations under the ASX Listing Rules, specifically Listing Rule 3.1.
- AR3 stated that it had no knowledge of any material change in its operations, financial position, or projects that would account for these unusual trading patterns.
- AR3 reaffirmed that all relevant information had been disclosed to the market and that it had not withheld any market-sensitive information.
- The company provided a standard response to the ASX Price Query, reiterating that any new or material developments would be released in accordance with disclosure requirements.
- The document includes the standard acknowledgments and declarations from company directors regarding the truthfulness and completeness of the response.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Unico Silver Limited (USL) ORDINARY FULLY PAID |
Materials |
$409 |
Notice of Initial Substantial Holder
|
17 Jul 2025 9:48AM |
$0.425 |
$0.645 |
risen by
51.76%
|
|
| Clarity Pharmaceuticals Ltd (CU6) ORDINARY FULLY PAID |
Health Care |
$892 |
Co-PSMA trial recruitment successfully completed
|
17 Jul 2025 9:45AM |
$3.410 |
$2.390 |
fallen by
29.91%
|
|
CU6 - Price-sensitive ASX Announcement
Full Release
Key Points
- Clarity Pharmaceuticals Ltd has successfully completed recruitment for the Co-PSMA trial.
- The trial is a Phase II imaging study of 64Cu-SAR-bisPSMA (CU6) for prostate cancer.
- Co-PSMA is a multi-center, open-label trial focused on safety and diagnostic accuracy in PET imaging.
- CU6 is a copper-based product candidate targeting prostate specific membrane antigen (PSMA).
- Successful recruitment is a critical milestone for Clarity’s copper theranostics pipeline.
- Results will inform further development and potential commercialization of CU6.
- Clarity expresses appreciation for participating patients, investigators, and sites.
- The trial aims to address unmet needs in prostate cancer imaging with a novel radiopharmaceutical.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Beacon Minerals Limited (BCN) ORDINARY FULLY PAID |
Materials |
$369 |
Completion of Consolidation
|
17 Jul 2025 9:45AM |
$1.150 |
$3.210 |
risen by
179.13%
|
|
| Immuron Limited (IMC) ORDINARY FULLY PAID |
Health Care |
$13 |
Application for quotation of securities - IMC
|
17 Jul 2025 9:44AM |
$0.065 |
$0.039 |
fallen by
40%
|
|
| Renegade Exploration Limited (RNX) ORDINARY FULLY PAID |
Materials |
$5 |
Trading Halt
|
17 Jul 2025 9:43AM |
$0.004 |
$0.003 |
fallen by
37.50%
|
|
RNX - Price-sensitive ASX Announcement
Full Release
Key Points
- Renegade Exploration Limited (ASX: RNX) requested a trading halt effective March 6, 2023.
- The trading halt relates to a pending announcement about a material acquisition.
- The halt is to last until either the announcement is made or trading resumes on March 8, 2023.
- The company is not aware of any reason why the trading halt should not be granted.
- Renegade Exploration Limited has no additional information required to inform the market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$6,683 |
Notification of cessation of securities - DNL
|
17 Jul 2025 9:42AM |
$2.840 |
$3.810 |
risen by
34.15%
|
|
| BPH Global Ltd (BP8) ORDINARY FULLY PAID |
Health Care |
$4 |
Second Month Seaweed Revenue Results Increase 17.7%
|
17 Jul 2025 9:42AM |
$0.002 |
$0.002 |
fallen by
25%
|
|
BP8 - Price-sensitive ASX Announcement
Full Release
Key Points
- BPH Global Ltd (ASX: BP8) announced its second month of seaweed revenue results.
- Gross revenue for the second month increased by 17.7% compared with the first month.
- The company is actively focused on scaling up its seaweed business in Malaysia.
- Revenue growth is attributed to increased harvesting and processing efficiency.
- BPH Global achieved higher production volumes and operational improvements.
- The company continues strategic efforts to expand its seaweed supply chain and market reach.
- Positive revenue results support BPH Global’s broader business goals and future growth.
- Management remains optimistic about ongoing seaweed revenue expansion and sector potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kingsgate Consolidated Limited (KCN) ORDINARY FULLY PAID |
Materials |
$1,349 |
Corporate Update
|
17 Jul 2025 9:41AM |
$2.450 |
$5.070 |
risen by
106.94%
|
|
| Nova Minerals Limited (NVA) CHESS DEPOSITARY INTERESTS 12:1 |
Materials |
$261 |
Nova Announces Closing of US$11.1m NASDAQ Offering
|
17 Jul 2025 9:41AM |
$0.235 |
$0.570 |
risen by
142.55%
|
|
NVA - Price-sensitive ASX Announcement
Full Release
Key Points
- Nova Minerals Limited completed a US$11.1 million IPO on NASDAQ.
- The IPO included ordinary shares and warrants.
- This milestone marks Nova's listing on a major US exchange.
- Proceeds will primarily fund the Estelle Gold Project in Alaska.
- The capital raised enhances Nova’s financial strength for exploration and development.
- The NASDAQ listing increases Nova’s visibility and access to US and international investors.
- The offering was managed by a US-based underwriter.
- The announcement details the transaction structure and use of funds.
- Proceeds will also support general corporate purposes and future exploration activities.
- The company expects strengthened growth prospects and operational flexibility post-listing.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cadence Capital Limited (CDM) ORDINARY FULLY PAID |
Financials |
$223 |
Change of Director's Interest Notice
|
17 Jul 2025 9:40AM |
$0.685 |
$0.745 |
risen by
8.76%
|
|
| Daintree Hybrid Opportunities Fund (Managed Fund) (DHOF) |
Financials |
$37 |
Investor Update June 2025
|
17 Jul 2025 9:39AM |
$9.640 |
$9.580 |
fallen by
0.62%
|
|
| Delta Corporation Limited (DCO) ORDINARY FULLY PAID |
- |
- |
Investor Update June 2025
|
17 Jul 2025 9:39AM |
n/a |
n/a |
n/a
|
|
| Cyprium Metals Limited (CYM) ORDINARY FULLY PAID |
Materials |
$246 |
Further $2.5M Progress Payment on Surplus Generator Sale
|
17 Jul 2025 9:38AM |
$0.034 |
$0.425 |
risen by
1,150%
|
|
| Nova Minerals Limited (NVA) CHESS DEPOSITARY INTERESTS 12:1 |
Materials |
$261 |
Application for quotation of securities - NVA
|
17 Jul 2025 9:37AM |
$0.235 |
$0.570 |
risen by
142.55%
|
|
| Norwest Minerals Limited (NWM) ORDINARY FULLY PAID |
Materials |
$9 |
Bulgera Gold Project drilling commences
|
17 Jul 2025 9:35AM |
$0.014 |
$0.008 |
fallen by
42.86%
|
|
| Macro Metals Limited (M4M) ORDINARY FULLY PAID |
Materials |
$27 |
Update to Strategic Placement to Paramount Earthmoving
|
17 Jul 2025 9:34AM |
$0.008 |
$0.006 |
fallen by
25%
|
|
M4M - Price-sensitive ASX Announcement
Full Release
Key Points
- Macro Metals Limited traded as ASX:M4M.
- Initial announcement of strategic alliance with Paramount Earthmoving was on 2 December 2024.
- $4 million placement via four tranches.
- First three tranches completed, totaling $3,019,256.
- Tranche 4 subscription can be deferred to as late as 30 September 2025.
- Decision based on Macro’s working capital requirements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
